Aligos Therapeutics, Inc.

Biotechnology company · South San Francisco, California, United States · Nasdaq: ALGS

Aligos Therapeutics, Inc. is a biotechnology company headquartered in South San Francisco, California, United States. Its earliest recorded incorporation is in 2018. Its shares trade on Nasdaq under the ticker ALGS. It has reported private securities offerings to the US SEC, most recently $105 million sold in a notice filed in 2025.

Profile compiled from public records. Is this your company? Request a correction or update

Aligos Therapeutics at a glance

Typebiotechnology company
HeadquartersSouth San Francisco, California, United States
Earliest incorporation on record2018
Stock listingNasdaq: ALGS
SEC industryBiological Products, (No Diagnostic Substances)
SEC CIK1799448

What does Aligos Therapeutics do?

Private fundraising reported to the SEC

3 Form D notices; the most recent reported $105 million sold (2025).

Frequently asked questions about Aligos Therapeutics

Where is Aligos Therapeutics headquartered?

Aligos Therapeutics, Inc. is headquartered in South San Francisco, California, United States.

What does Aligos Therapeutics do?

Aligos Therapeutics, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).

Is Aligos Therapeutics a public company?

Yes. Aligos Therapeutics, Inc. trades on Nasdaq under the ticker ALGS.

When was Aligos Therapeutics founded?

The earliest incorporation on record for Aligos Therapeutics, Inc. is in 2018, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.

Aligos Therapeutics: Headquarters, Locations & Company Profile (2026) | BioBridgeX